113 related articles for article (PubMed ID: 38158359)
1. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
[TBL] [Abstract][Full Text] [Related]
2. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
Distler M; Pilarsky E; Kersting S; Grützmann R
Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
[TBL] [Abstract][Full Text] [Related]
3. Prognostic analysis of patients with pancreatic head adenocarcinoma less than 2 cm undergoing resection.
Chiang KC; Yeh CN; Lee WC; Jan YY; Hwang TL
World J Gastroenterol; 2009 Sep; 15(34):4305-10. PubMed ID: 19750574
[TBL] [Abstract][Full Text] [Related]
4. Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma.
Lee KJ; Yi SW; Chung MJ; Park SW; Song SY; Chung JB; Park JY
Yonsei Med J; 2013 May; 54(3):643-9. PubMed ID: 23549809
[TBL] [Abstract][Full Text] [Related]
5. Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.
Kanda M; Fujii T; Takami H; Suenaga M; Inokawa Y; Yamada S; Nakayama G; Sugimoto H; Koike M; Nomoto S; Kodera Y
Surg Today; 2014 Sep; 44(9):1692-701. PubMed ID: 24114022
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19-9 in periampullary cancer patients receiving pancreaticoduodenectomy.
Park SH; Shin JH; Jung KU; Lee SR
Asian J Surg; 2021 Jun; 44(6):829-835. PubMed ID: 33478861
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
8. De Ritis Ratio as a Significant Prognostic Factor in Patients with Sepsis: A Retrospective Analysis.
Zhao PY; Yao RQ; Ren C; Li SY; Li YX; Zhu SY; Yao YM; Du XH
J Surg Res; 2021 Aug; 264():375-385. PubMed ID: 33848836
[TBL] [Abstract][Full Text] [Related]
9. Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study.
Esen E; Aslan M; Morkavuk SB; Azili C; Ersoz S; Bahcecioglu IB; Unal AE
Medicine (Baltimore); 2023 Mar; 102(11):e33325. PubMed ID: 36930073
[TBL] [Abstract][Full Text] [Related]
10. Is a preoperative assessment of the early recurrence of pancreatic cancer possible after complete surgical resection?
La Torre M; Nigri G; Lo Conte A; Mazzuca F; Tierno SM; Salaj A; Marchetti P; Ziparo V; Ramacciato G
Gut Liver; 2014 Jan; 8(1):102-8. PubMed ID: 24516708
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
[TBL] [Abstract][Full Text] [Related]
12. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
14. Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
Zhang Z; Li Y; Wu Y; Bi R; Wu X; Ke G; Zhu J
Int J Biol Markers; 2023 Dec; 38(3-4):223-232. PubMed ID: 37933442
[TBL] [Abstract][Full Text] [Related]
15. Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma.
Kim J; Lee YS; Hwang IK; Kang BK; Cho JY; Yoon YS; Han HS; Hwang JH
J Korean Med Sci; 2015 Mar; 30(3):259-63. PubMed ID: 25729247
[TBL] [Abstract][Full Text] [Related]
16. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
17. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
18. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
19. The aspartate transaminase/alanine transaminase (DeRitis) ratio predicts mid-term mortality and renal and respiratory dysfunction after left ventricular assist device implantation.
Pilarczyk K; Carstens H; Heckmann J; Canbay A; Koch A; Pizanis N; Jakob H; Kamler M
Eur J Cardiothorac Surg; 2017 Oct; 52(4):781-788. PubMed ID: 29156019
[TBL] [Abstract][Full Text] [Related]
20. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
